Glucagon-like peptide-1 receptor agonists for improving cardiorenal outcomes in type 1 diabetes mellitus?

Article Endocrinology & Metabolism

Double Diabetes: A Growing Problem Requiring Solutions

Djordje S. Popovic et al.

Summary: The growing proportion of T1DM patients with clinical features of IR has led to the identification of a distinct subgroup called double diabetes, which is associated with poorer metabolic phenotype and increased risk of complications. The goal is to timely identify double diabetes and implement appropriate interventions to reduce the risk of complications. Proposed diagnostic criteria include family history of T2DM, obesity/metabolic syndrome, and IR. Glucose disposal rate may be the most reliable marker. Double diabetes patients may benefit from agents developed for T2DM.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2022)

Add to Collection

Article Endocrinology & Metabolism

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies et al.

Summary: The American Diabetes Association and the European Association for the Study of Diabetes have updated the consensus statements on the management of hyperglycemia in adults with type 2 diabetes. The new recommendations highlight the importance of social determinants of health, weight management, and provide practical tips for implementation.

DIABETES CARE (2022)

Add to Collection

Article Endocrinology & Metabolism